DLPN Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
DLPN is not a good buy right now for a beginner long-term investor with $50,000-$100,000 to deploy. The stock lacks a clear bullish technical setup, there is no positive news catalyst, analyst activity is unavailable, and options sentiment is skewed bullish but thinly traded. The business does show revenue growth, but profitability weakened sharply in the latest quarter, so the current setup does not justify an immediate buy.
Price is closed at 1.41, sitting just below the pivot level of 1.455 and above support at 1.367. MACD histogram is slightly negative at -0.00564 but contracting, which suggests downside momentum is fading. RSI_6 at 38.963 is neutral to weak, and moving averages are converging, indicating a range-bound market rather than a strong uptrend. The short-term pattern data suggests possible near-term upside, but the overall technical picture is still undecisive and not a strong entry signal.
Revenue in 2025/Q4 increased 27.02% year over year to 15.65M, and gross margin improved to 92.83%, showing strong top-line expansion and excellent margin structure. The option open interest skew is bullish, and the stock trend model suggests a 60% chance of a 5.56% move higher in the next day and 10.59% over the next month. Hedge funds and insiders were neutral, so there is no negative positioning pressure from those groups.
Net income fell 152.04% year over year to 1.02M and EPS dropped 147.06% to 0.08 in 2025/Q4, showing that profitability weakened materially despite revenue growth. There has been no news in the recent week, so there is no event-driven catalyst. AI Stock Picker has no signal today, and SwingMax has no recent signal. Hedge fund and insider activity are neutral, analyst rating and target changes are not available, and there is no recent congress trading activity.
In 2025/Q4, DLPN posted revenue of 15,645,840, up 27.02% year over year, which is a solid growth trend. Gross margin improved to 92.83%, up 2.24 points year over year, indicating strong operating efficiency. However, net income declined sharply to 1,019,706 and EPS dropped to 0.08, both down more than 147% year over year, so earnings quality is weak despite the sales growth.
No recent analyst rating trend or price target change data was provided, so the Wall Street pros and cons view cannot be confirmed from the dataset. Based on the available information, the pro side is revenue growth and high gross margin, while the con side is deteriorating earnings, lack of news catalysts, and no clear institutional or insider support.
